@misc{indiciae45a73d191a4b,
  title = {FGFR2 promotes resistance to ALK tyrosine kinase inhibitors and its inhibition acts synergistically with lorlatinib in the treatment of ALK-expressing neuroblastoma},
  author = {Pucci, P. and Barrett, C. and Trigg, R. and Matthews, J. D. and Borenas, M. and Schlederer, M. and Jahangiri, L. and Hare, L. and Steel, C. and James, E. and Prokoph, N. and Kenner, L. and Palmer, R. and Hallberg, B. and Burke, A. and Turner, S. D.},
  year = {2024},
  doi = {10.1101/2024.09.05.611416},
  url = {https://www.biorxiv.org/content/10.1101/2024.09.05.611416v1},
  note = {Source identifier: 10.1101/2024.09.05.611416}
}